Artículo

Isavuconazole activity against emerging fungal pathogens with reduced azole-susceptibility: Aspergillus lentulus, Neosartorya udagawae and Cryptococcus gattii

Datta, K.; Rhee, P.; Byrnes III, E.; Garcia, Guillermo ManuelIcon ; Perlin, D. S.; Staab, J. F.; Marr, K. A.
Fecha de publicación: 06/2013
Editorial: American Society For Microbiology
Revista: Journal of Clinical Microbiology
ISSN: 0095-1137
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:

Resumen

Isavuconazole is an extended-spectrum triazole with in vitro activity against a wide variety of fungal pathogens. Clinical isolates of molds Aspergillus lentulus and Neosartorya udagawae and yeast Cryptococcus gattii VGII (implicated in the outbreak in the Pacific Northwest, North America) exhibit reduced susceptibilities to several azoles but higher susceptibilities to isavuconazole.
Palabras clave: Isovuconazol , Susceptibility , Aspergillus Lentulus , Cryptococcus Gatti
 
Archivos asociados
Thumbnail
 
Tamaño: 199.7Kb
Formato: PDF
.
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Identificadores
URI: http://hdl.handle.net/11336/6512
DOI: http://dx.doi.org/10.1128/JCM.01190-13
DOI: http://dx.doi.org/ 10.1128/JCM.01190-13
URL: http://jcm.asm.org/content/51/9/3090
Colecciones
Articulos(CCT - SANTA FE)
Articulos de CTRO.CIENTIFICO TECNOL.CONICET - SANTA FE
Citación
Datta, K.; Rhee, P.; Byrnes III, E.; Garcia, Guillermo Manuel; Perlin, D. S.; et al.; Isavuconazole activity against emerging fungal pathogens with reduced azole-susceptibility: Aspergillus lentulus, Neosartorya udagawae and Cryptococcus gattii; American Society For Microbiology; Journal of Clinical Microbiology; 51; 9; 6-2013; 3090-3093
Compartir
Altmétricas